
Regeneron's Livsayis (cemdisiran) gains FDA approval for adults with antibody-positive generalized myasthenia gravis, dosed four times a year.
European Sales Manager
James Gray
European Sales Manager
T: +44(0)1244 393202
F: +44(0)1244 383356
Handles sales for Europe, Asia Pacific and Latin America






